Avandia (rosiglitazone), which is use for type 2 diabetes treatment will undergo a pack change in NZ, to bring it into line with Australia, stocks. Glaxosmithkline NZ Limited (GSK) will start implementing these changes over the next few months. Here is a peak of the old and new pack.